Evaluation of LNA-modified DNAzymes targeting a single nucleotide polymorphism in the large subunit of RNA polymerase II

Oligonucleotides

Volumn 15, Issue 4, 2005, Pages 246-254

  Fluiter, Kees ^a   Frieden, Miriam ^b   Vreijling, Jeroen ^a   Koch, Troels ^b   Baas, Frank ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Santaris Pharma AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA; ENZYME; LOCKED NUCLEIC ACID; MESSENGER RNA; PHOSPHOROTHIOIC ACID DERIVATIVE; RIBONUCLEASE H; RNA POLYMERASE II;

ALLELE; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL FREE SYSTEM; CELL KILLING; CELL TYPE; ENZYME SUBUNIT; EVALUATION; FEASIBILITY STUDY; GENE TARGETING; HETEROZYGOSITY LOSS; HETEROZYGOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; RNA CLEAVAGE; RNA DEGRADATION; SINGLE NUCLEOTIDE POLYMORPHISM; TARGET CELL;

BASE SEQUENCE; CELL LINE, TUMOR; DNA, CATALYTIC; HUMANS; KINETICS; MALE; NUCLEIC ACID CONFORMATION; NUCLEIC ACIDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA POLYMERASE II; RNA, MESSENGER;

EID: 30844457323     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2005.15.246     Document Type: Article

References (25)

1. BASILION, J.P., SCHIEVELLA, A.R., BURNS, E., RIOUS, P., OLSON, J.C., MONIA, B.P., LEMONIDIS, K.M., STANTON, V.P., and, HOUSMAN, D.E. (1999). Selective killing of cancer cells based on loss of heterozygosity and normal variation in the human genome: A new paradigm for anticancer drug therapy. Mol. Pharmacol. 56, 359-369.
2. CIESLAK, M., SZYMANSKI, J., ADAMIAK, R.W., and CIERNIEWSKI, C.S. (2003). Structural rearrangements of the 10-23 DNAzyme to beta 3 integrin subunit mRNA induced by cations and their relations to the catalytic activity. J. Biol. Chem. 278, 47987-47996.
3. FAHMY, R.G., and KHACHIGIAN, L.M. (2004). Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth. Nucleic Acids Res. 32, 2281-2285.
4. FELDMAN, A.R., and SEN, D. (2001). A new and efficient DNA enzyme for the sequence specific cleavage of RNA. J. Mol. Biol. 313, 283-294.
5. FLUITER, K., HOUSMAN, D., TEN ASBROEK, A.L.M.A., and BAAS, F. (2003a). Killing cancer by targeting genes that cancer cells have lost: Allele-specific inhibition, a novel approach to the treatment of genetic disorders. Cell. Mol. Life Sci. 60, 834-843.
6. FLUITER, K., TEN ASBROEK, A.L.M.A., DE WISSEL, M.B., JAKOBS, M.E., WISSENBACH, M., OLSSON, H., OLSEN, O., OERUM, H., and BAAS F. (2003b). In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides. Nucleic Acids Res. 31, 953-962.
7. FLUITER, K., TEN ASBROEK, A.L.M.A., VAN GROENINGEN, M., NOOIJ, M., AALDERS, M.C.G., and BAAS, F. (2002). Tumor genotype specific growth inhibition in vivo by antisense oligonucleotides against a polymorphic site of the large subunit of human RNA polymerase II. Cancer Res. 62, 2024-2028.
8. FRIEDEN, M., CHRISTENSEN, S.M., MIKKELSEN, N.D., ROSENBOHM, C., THRUE, C.A., WESTERGAARD, M., HANSEN, H.F., ORUM, H., and KOCH, T. (2003). Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA. Nucleic Acids Res. 31, 6365-6372.
9. HUIJGEN, H.J., SANDERS, R., VAN OLDEN, R.W., KLOUS, M.G., GAFFAR, F.R., and SANDERS, G.T. (1998). Intracellular and extracellular blood magnesium fractions in hemodialysis patients: Is the ionized fraction a measure of magnesium excess? Clin. Chem. 44, 639-648.
10. JOYCE, G.F. (2001). RNA cleavage by the 10-23 DNA enzyme. Methods Enzymol. 341, 503-517.
11. KOSHKIN, A., SINGH, S.K., NIELSEN, P., RAJWANSHI, V.K., KUMAR, R., MELGAARD, M., OLSEN, C.E., and WENGEL, J. (1998). LNA: Synthesis of the adenine, cytosine, guanine 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation and unprecedented nucleic acid recognition. Tetrahedron 54, 3607-3630.
12. KURRECK, J., WYSZKO, E., GILLEN, C., and ERDMANN, V. A. (2002). Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 30, 1911-1918.
13. LENGAUER, C., KINZLER, K.W., and VOGELSTEIN, B. (1998). Genetic instabilities in human cancers. Nature 396, 643-649.
14. MITCHELL, A., DASS, C.R., SUN, L.Q., and KHACHIGIAN, L.M. (2004). Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acids Res. 32, 3065-3069.
15. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
16. SANTORO, S.W., and JOYCE, G.F. (1997). A general-purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. USA 94, 4262-4266.
17. SCHUBERT, S., FURSTE, J.P., WERK, D., GRUNERT, H.P., ZEICHHARDT, H., ERDMANN, V.A., and KURRECK, J. (2004). Gaining target access for deoxyribozymes J. Mol. Biol. 339, 355-363.
18. SCHUBERT, S., GUL, D.C., GRUNERT, H.P., ZEICHHARDT, H., ERDMANN, V.A., and KURRECK, J. (2003). RNA cleaving 10-23 DNAzymes with enhanced stability and activity. Nucleic Acids Res. 31, 5982-5992.
19. SHEN, L.X., BASILION, J.P., and STANTON, V.P., JR. (1999). Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc. Natl. Acad. Sci. USA 96, 7871-7876.
20. TEN ASBROEK, A.L.M.A., FLUITER, K., VAN GROENIGEN, M., NOOIJ, M., and BAAS, F. (2000). Polymorphisms in the large subunit of human RNA polymerase II as target for allele-specific inhibition. Nucleic Acids Res. 28, 1133-1138.
21. TEN ASBROEK, A.L.M.A., OLSEN, J., HOUSMAN, D., BAAS, F., and STANTON, V.P., JR. (2001). Genetic variation in mRNA coding sequences of highly conserved genes. Physiol. Genomics 5, 113-118.
22. TEN ASBROEK, A.L.M.A., VAN GROENIGEN, M., NOOIJ, M., and BAAS, F. (2002). The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides. Eur. J. Biochem. 269, 583-592.
23. VESTER, B., LUNDBERG, L.B., SORENSEN, M.D., BABU, B.R., DOUTHWAITE, S., and WENGEL, J. (2002). LNAzymes: Incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage. J. Am. Chem. Soc. 124, 13682-13683.
24. VISSER, M., SIJMONS, C.C., BRAS, J., ARCECI, R.J., GODFRIED, M., VALENTIJN, L.J., VOÛTE, P.A., and BAAS, F. (1997). Allelotype of pediatric rhabdomyosarcoma. Oncogene 15, 1309-1314.
25. WAHLESTEDT, C., SALMI, P., GOOD, L., KELA, J., JOHNSSON, T., HOKFELT, T., BROBERGER, C., PORRECA, F., LAI, J., REN, K., OSSIPOV, M., KOSHKIN, A., JAKOBSEN, N., SKOUV, J., OERUM, H., JACOBSEN, M.H., and WENGEL, J. (2000). Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl. Acad. Sci. USA 97, 5633-5638.